Ricardo Chiattone
A5020060146- Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia research
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Healthcare during COVID-19 Pandemic
- Neutropenia and Cancer Infections
- Oral health in cancer treatment
- Mesenchymal stem cell research
- CAR-T cell therapy research
- Chronic Myeloid Leukemia Treatments
- Public Health in Brazil
- Cardiovascular Syncope and Autonomic Disorders
- Lymphatic System and Diseases
- Multiple Myeloma Research and Treatments
- Leprosy Research and Treatment
- Attention Deficit Hyperactivity Disorder
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Health, Nursing, Elderly Care
- Herpesvirus Infections and Treatments
- Vascular Tumors and Angiosarcomas
- Childhood Cancer Survivors' Quality of Life
- Oral and Craniofacial Lesions
- Oral and gingival health research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Hospital Samaritano de São Paulo
2014-2024
Hospital Amaral Carvalho
2011-2024
UnitedHealth Group (United States)
2020
Irmandade da Santa Casa de Misericórdia de São Paulo
2013-2016
Faculdade de Ciências Médicas da Santa Casa de São Paulo
2015
Santa Casa Hospital
2013
Hospital São Paulo
2011
Background Accurate prediction of stem cell yield is important for planning leukapheresis procedures. A formula has been published ( P ierelli et al., V ox S ang 2006;91:126‐34) to estimate the CD 34+ dose collected on first day that was based preapheresis peripheral blood PB ) counts, volume processed, and donor's weight. The aim this study assess predictive value formula. Study Design Methods Data were retrospectively 1126 consecutive harvests conducted at five institutions. Information...
The objective of this study was to compare the major transplant outcomes between patients receiving hematopoietic stem cell transplantation (HSCT) from bone marrow (BM) or peripheral blood cells (PBSC).All consecutive HSCT using BM PBSC an HLA-matched related donors for haematological malignancies after high intensity conditioning at seven Brazilian centres January 2008 and December 2009 were retrospectively evaluated.In period, 334 treated in included evaluation. cumulative incidence grades...
The nutritional status of patients submitted to hematopoietic stem cell transplant is considered an independent risk factor, which may influence on quality life and tolerance the proposed treatment. impairment during occurs mainly due adverse effects resulting from conditioning patient subjected. Therefore, adequate evaluation follow-up are essential. To emphasize importance body composition treatment, as well main characteristics related assessment patient, Brazilian Consensus Nutrition in...
The development of the Brazilian Registry Hematopoietic Cell Transplantation in collaboration with Center for International Blood and Marrow Transplant Research (CIBMTR) allowed an assessment activity general outcomes transplants Brazil. Here, we report updated activity. transplant centers their data to CIBMTR, using FormsNet3 platform. Information returns Cellular Therapy Bone Society (SBTMO) through Data Back Centers (DBtC) tool. from patients who received HCT 2012 2023 were extracted...
Chimeric antigen receptor T-cells (CAR T cells) are genetically modified cellular immunotherapies approved for standard of care treatment patients with lymphoma and leukemia worldwide. Here we report the initial activity in Brazilian centers through collaboration between Cellular Therapy Bone Marrow Transplant Society (SBTMO) Center International Blood Research (CIBMTR). A total 38 who received CAR cells 2020 2023. The median age was 47 years (range 4-77). Indications include Non-Hodgkin...
The first hematopoietic stem cell transplantation (HSCT) program in Latin America started 1979 at the federal university hospital Curitiba, Paraná, Brazil. Over years, number of centers performing transplants our country has increased tremendously, generating need to know results this treatment modality. Understanding HSCT scenario Brazil is still challenging, since not all Brazilian report data Center for International Blood and Marrow Research (CIBMTR). Despite improvement reporting over...
The Lee Chronic Graft-versus-Host Disease (GVHD) Symptom Scale is a patient-reported instrument developed and validated in English to measure the symptoms functional impact of cGVHD. This tool has not yet been Latin American population, however. Brazil-Seattle GVHD Consortium conducted multicenter study at 5 Brazilian institutions validate cGVHD adults with Study objectives included translation validation Portuguese evaluation correlation other quality life (QoL) tools, including Medical...
The first HSCT program in Latin America started 1979 at the Federal University Hospital (Curitiba, Paraná). Over years, number of centers performing transplants country increased, generating need to know results this modality treatment. Understanding scenario Brazil is still challenging since not all Brazilian report data Center for International Blood and Marrow Research (CIBMTR). Although it has been improving over last infrastructure trained managers are lacking. partnership between...
Understanding the HSCT scenario in Brazil is challenging due to lack of a national registry that allows analysis results. The partnership between Brazilian Cellular Therapy and Bone Marrow Transplant Society (SBTMO) Center for International Blood Research (CIBMTR) allowed return data registered CIBMTR, through Data Back (DBtC), standardized organized way. With this database it was possible know demographic outcomes transplants performed Brazil. spreadsheet imported into Power BI desktop,...
This is an observational and cross-sectional study, carried out in May 2020, targeting adult individuals of both sexes who are members multiprofessional teams working Brazilian HSCT units the current period pandemic by completing analyzing a questionnaire. pre-formulated. that cannot access questionnaire were excluded from study. The analysis operation profile Brazil, through application pre-structured questionnaire, not accurate tool, since it assumes some premises may prove to be wrong,...
The treatment and evolution of B-cell non-Hodgkin lymphoma (B-NHL) has undergone important changes in the last years with emergence targeted therapies, such as monoclonal antibodies, small molecules, antibody-drug conjugates, bispecific antibodies. Nevertheless, a significant portion patients remains refractory or relapsed (R/R) to new therapeutic modalities, representing thus an unmet medical need. use CAR-T cells for B-NHL shown be promising therapy impressive results R/R disease....
A amiloidose é caracterizada pela deposição extracelular de uma proteína fibrilar insolúvel cadeia pesada em órgãos e tecidos pode ser classificada como primária ou secundária. Relato Caso: Um paciente do gênero masculino, 62 anos, apresentou queixa dor lombar acompanhada por macroglossia. biópsia língua confirmou o diagnóstico amiloidose. O tratamento instituído foi transplante autólogo células-tronco hematopoéticas. exame físico intraoral no período mostrou macroglossia, lábios mucosa...
The cGVHD Symptom Bother Scale, known as the Lee scale, is a patient reported questionnaire developed and validated in English to measure symptoms functional losses patients (pts.) with cGVHD. scale includes 30 questions 7 subscales containing 2 items representing domains of skin, mouth, respiratory system, gastrointestinal energy psychological status. was translated into Portuguese according American Association Orthopedic Surgeons Outcome Committee guideline. 47 adult pts diagnosed 2005...
Management of acute lymphoblastic leukemia (ALL) in a socioeconomically vulnerable population without ready access to hematopoietic stem cell transplant (HCT) center and clinical trials is challenging. Data regarding the outcomes such patients are sparse.This retrospective analysis included 90 consecutive with ALL who presented Harbor-UCLA between 2003 2018. The primary objective was overall survival (OS), whereas secondary objectives leukemia-free survival, toxicities therapy, referral for...